Drug Recalls - Stock Screener

Drug Recalls

Stock Screener

Drug recalls are essential for pharma companies. Here you can analyze the latest and past ones in full data breadth. How many drugs are affected? What is the reason for the recall and where is it taking place?

Export

Ticker	Filing	Report	Start	Termination	Drug/Supplement	Quantity	Quantity measure	Classification	Reason for recall	Distribution pattern	Voluntary mandated	Initial firm notification
GILD	FDA	10/09/2024	09/19/2024	—	REMDESIVIR	105,000.00	vials	1	Presence of Particulate Matter: Presence of glass particle.	Nationwide in the U.S.A.	1	Letter
ABBV	FDA	10/02/2024	09/16/2024	—	—	2,473,563.00	tubes	2	Lack of Assurance of Sterility: The impacted lots may contain a breach in the tube seal.	Nationwide in the USA, Foreign Consignees (Austrailia, Canada, Great Britain)	1	Letter
ABBV	FDA	10/02/2024	09/16/2024	—	—	763,426.00	tubes	2	Lack of Assurance of Sterility: The impacted lots may contain a breach in the tube seal.	Nationwide in the USA, Foreign Consignees (Austrailia, Canada, Great Britain)	1	Letter
PFE	FDA	07/03/2024	05/20/2024	—	LABETALOL HYDROCHLORIDE	220,400.00	cartridges	2	Lack of Assurance of Sterility-The potential for incomplete crimp seals.	US Nationwide and Puerto Rico.	1	Letter
PFE	FDA	07/03/2024	05/20/2024	—	BUPRENORPHINE HYDROCHLORIDE	84,710.00	cartridges	2	Lack of Assurance of Sterility-The potential for incomplete crimp seals.	US Nationwide and Puerto Rico.	1	Letter

Filtering "Drug Recalls"

You are not authenticated to access the filter function for this screener.

Unlock Now